Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort

Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Willy Theel, Willem-Pieter Brouwer, Elisabeth van Rossum, Jan Apers, Susan ter Borg, Tessa Noordermeer, Manuel Castro Cabezas
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186956/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort.
by: Willy Theel, et al.
Published: (2025-01-01)

Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH
by: Ali H. Eid, et al.
Published: (2025-05-01)

Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH
by: Thomas Zöggeler, et al.
Published: (2025-12-01)

Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways
by: Shi-Long Wang, et al.
Published: (2025-07-01)

Gaps in MASLD/MASH Education: A Quantitative and Qualitative Survey with Leaders of US Graduate Medical Education Programs
by: Allen AM, et al.
Published: (2025-05-01)

Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
by: Julie S. Pedersen, et al.
Published: (2025-04-01)

Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD‐MASH Transition by Disrupting Carnitine Biosynthesis
by: Senlin Lian, et al.
Published: (2025-05-01)

The Value of TyG-Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD
by: Haoxuan Zou, et al.
Published: (2025-01-01)

Association of serum iron status with MASLD and liver fibrosis.
by: Wenying Guo, et al.
Published: (2025-01-01)

Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials
by: Hazem Ayesh, et al.
Published: (2024-10-01)

Predicting Fibrosis Stage in MASH: The Role of Total Metabolic Syndrome Score and MMP-1
by: Bahadır Köylü, et al.
Published: (2025-06-01)

A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis
by: Jeong-Su Park, et al.
Published: (2025-02-01)

INHIBITION OF THE PROSTAGLANDIN-DEGRADING ENZYME 15-PGDH AMELIORATES MASH-ASSOCIATED APOPTOSIS AND FIBROSIS IN MICE
by: Utibe-Abasi S. Udoh, et al.
Published: (2025-06-01)

Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
by: Johnny Amer, et al.
Published: (2025-06-01)

Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study
by: Manuel Castro Cabezas, et al.
Published: (2025-05-01)

Double Dutch: The Boate Brothers and Colonial Cosmography
by: Willy Maley
Published: (2023-03-01)

Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD
by: Yanqi Lan, et al.
Published: (2025-08-01)

Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
by: Tianyuan Yang, et al.
Published: (2025-04-01)

Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
by: Jianhua Zhang, et al.
Published: (2025-04-01)

A systematic review and meta-analysis of efruxifermin’s efficacy in improving liver fibrosis in patients with NASH/MASH
by: Shuzhai Li, et al.
Published: (2025-05-01)

AI‐Based Platelet‐Independent Noninvasive Test for Liver Fibrosis in MASLD Patients
by: Shun‐ichi Wakabayashi, et al.
Published: (2025-04-01)

Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study.
by: Wenying Guo, et al.
Published: (2024-01-01)

Content validity of self-reports of excess skin after bariatric surgery: protocol for a Dutch cross-sectional study
by: Rinie Geenen, et al.
Published: (2025-07-01)

USP24 upregulation stabilizes PKA-Cα to promote lipogenesis, inflammation, and fibrosis during MASH progression
by: Beh Ning, et al.
Published: (2025-05-01)

The role of lipoprotein sulfatides in MASLD fibrosis transition: A new frontier in hepatic immunomodulation
by: Yifan Zhou, et al.
Published: (2025-03-01)

Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis
by: Linjing Long, et al.
Published: (2025-03-01)

Evaluating the Effectiveness of Pegbelfermin in MASH‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials
by: Muhammad Shahzil, et al.
Published: (2025-03-01)

Food Biodiversity and Diet Quality in Dutch Adults
by: Rosalie Bakker, et al.
Published: (2024-02-01)

The approach to a pregnancy after bariatric surgery
by: Harriet D Morgan, et al.
Published: (2025-01-01)

Summative assessment in Dutch bilingual secondary education
by: Tessa Mearns, et al.
Published: (2025-05-01)

Adaptation and validation of the motivated strategies for learning questionnaire for Dutch pre-vocational students
by: Bernard Brouwer, et al.
Published: (2025-07-01)

Resmetirom: The First Disease-Specific Treatment for MASH
by: Ali Mohamed Mousa, et al.
Published: (2025-01-01)

Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01)

Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study
by: Haoyu Zhang, et al.
Published: (2025-07-01)

Physical activity, diet, and social determinants of health associate with health related quality of life and fibrosis in MASLD
by: Blake C. Czapla, et al.
Published: (2025-03-01)

Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease
by: Yunfei Wu, et al.
Published: (2025-03-01)

OPN‐Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH‐Associated Liver Fibrosis
by: Sujuan Wang, et al.
Published: (2024-12-01)

Metabolic Bone Disease in the Bariatric Surgery Patient
by: Susan E. Williams
Published: (2011-01-01)

Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD – a prospective interventional study
by: Adam Vašura, et al.
Published: (2025-01-01)

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
by: Donghee Kim, et al.
Published: (2025-07-01)